Lupin Partners with Chinese Firm for Obesity Drug: A Game-Changer for Indian Healthcare
Lupin signs licensing, supply, and distribution deal with China-based Gan & Lee Pharmaceuticals for a novel obesity and diabetes medication, strengthening its diabetes portfolio and accelerating its presence in the obesity segment.